Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Debt to Equity: 2020-2021

Historic Debt to Equity for ENDRA Life Sciences (NDRA) over the last 2 years, with Sep 2021 value amounting to $0.04.

  • ENDRA Life Sciences' Debt to Equity fell 56.28% to $0.04 in Q3 2021 from the same period last year, while for Sep 2021 it was $0.04, marking a year-over-year decrease of 56.28%. This contributed to the annual value of $0.05 for FY2020, which is N/A change from last year.
  • As of Q3 2021, ENDRA Life Sciences' Debt to Equity stood at $0.04, which was up 7.75% from $0.04 recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Debt to Equity ranged from a high of $0.35 in Q2 2020 and a low of $0.00 during Q1 2021.
  • Moreover, its 2-year median value for Debt to Equity was $0.05 (2021), whereas its average is $0.10.
  • Data for ENDRA Life Sciences' Debt to Equity shows a maximum YoY slumped of 88.12% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows ENDRA Life Sciences' Debt to Equity stood at $0.05 in 2020, then crashed by 56.28% to $0.04 in 2021.
  • Its Debt to Equity stands at $0.04 for Q3 2021, versus $0.04 for Q2 2021 and $0.00 for Q1 2021.